Preclinical efficacy of growth hormone-releasing hormone antagonist MIA-602 for androgen-dependent and castration-resistant human prostate cancer.
Ferenc G. Rick
No relevant relationships to disclose
Cale D. Fahrenholtz
No relevant relationships to disclose
Maria I. Garcia
No relevant relationships to disclose
Norman L. Block
No relevant relationships to disclose
Andrew V. Schally
No relevant relationships to disclose
Kerry L. Burnstein
No relevant relationships to disclose